Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease

The resolution of proteinuria in LN is slow. MLN is not a benign disease and may be associated with deterioration of renal function, ESKD, damage, CV events and death.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2024-08-10
DOI
https://doi.org/10.1093/rheumatology/keae436
Citations
14
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
6.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease

Zahi Touma, Arenn Jauhal, Laura P Whittall Garcia, Fadi Kharouf et al.
14 citations
Lara D. Veeken
Systemic Lupus Erythematosus Research
6.58
article

Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease

Zahi Touma, Arenn Jauhal, Laura P Whittall Garcia, Fadi Kharouf, Qixuan Li, D. Gladman
article en
14 citations

Abstract

The resolution of proteinuria in LN is slow. MLN is not a benign disease and may be associated with deterioration of renal function, ESKD, damage, CV events and death.

Lara D. VeekenVol. 64(4)
University Health Network (CA), University of Toronto (CA), Krembil Research Institute
University Health Network
Good health and well-being
Openalex Percentile: Top 3%
Systemic Lupus Erythematosus Research
6.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.